glp 1 indication GLP-1 Agonists: Using Semaglutide, Tirzepatide, and Orforglipron for Weight Loss and Obesity 2025 Update ✨ GLP-1 and

doi:10.1210/en.2013-1934 Nauck MA, Niedereichholz U, Ettler R, et al

Wegovy: Conditions treated Contrave and Wegovy are used for chronic weight management in adults with a significant body mass index (BMI)

In Massachusetts, the governors proposed fiscal 2028 budget would not fund the states Medicaid program, MassHealth, to cover GLP-1 medications for weight loss alone, though the state would continue covering the drugs for diabetes and other conditions

Prohormone convertase 1 (PC1

For the first time in more than 20 years, Medicare will help cover the cost of prescription medication specifically for obesity, giving eligible beneficiaries access to semaglutide, tirzepatide, or orforglipron for around $50 a month through the end of 2027